Edinburgh, United Kingdom · Founded 2019 · Privately Held (backing)
Operator of a veterinary diagnostics company intended to develop and market testing technology for early-stage heart disease in companion animals. MI:RNA is based in Edinburgh, United Kingdom and was founded in 2019. It was valued at $9.6 million at its later-stage round in Jul 2024, the last priced event on record. It has raised $9.2 million across 2 recorded rounds; the latest was a $4.4 million seed round in Jun 2024.
PMV mark · valuation
$9.6M
Oct 2026
Priced at
its later-stage round
Jul 2024
Total raised
$9.2M
Last round
Seed Round
Jun 2024
Cap table — not yet on record
MI:RNA's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MI:RNA with a free account
·The complete investor list: 16 names
·Watch MI:RNA: the Monday email on marks, rounds and moves